Abstract:Image-guided stimulus-responsive theranostics are beneficial for identifying malignant lesions and integrating multiple cell-killing mechanisms to enhance tumor cell clearance. Herein, an intelligent dual-responsive nanostructure (HSPMH-DOX) was developed for magnetic resonance imaging (MRI)-guided synergistic chemo-photothermal therapy (PTT) and chemodynamic therapy (CDT). The core-shell nanostructure was synthesized by layering polydopamine (PDA), manganese oxide (MnO 2 ), and hyaluronic acid (HA) onto drug-loaded hollow mesoporous silica nanoparticles (HS). The constructed nanoagent has both endogenous and external dual responses. The tumor microenvironment (pH/GSH) can trigger the degradation of gatekeeper (MnO 2 and PDA), resulting in the release of anti-tumor drugs, whereas external near-infrared light irradiation can accelerate the degradation process and generate local overheating, resulting in PTT. Notably, MnO 2 can not only consume intracellular GSH to enhance CDT but also release Mn 2+ for precise localization of tumor tissues using MRI. Both in vitro and in vivo experiments showed that the prepared dual-response nanoagent satisfied biocompatibility, targeting, and the great efficiency of MRI-guided combined therapy. In animal models, combining chemo-PTT and CDT can eradicate tumors in less than two weeks. This work could pave the way for a wide range of stimulus-responsive synergistic theranostic applications, including MRI, chemo-photothermal therapy, and chemodynmic therapy. Statement of Significance Low bioavailability and severe side effects remain the major limitations of conventional cancer chemotherapy. Image-guided combination therapy can alleviate these problems and improve tumor-specific therapy. In the present study, the anticancer drug doxorubicin was encapsulated in a core-shell hollow mesoporous silica nanostructure (HSPMH-DOX), enabling MRI-guided targeted release under both endogenous and external dual stimuli. Moreover, the photothermal and nanoenzymatic effects of nanomedicine can cause local overheating in the tumor and amplify the intracellular CDT effect, accelerating tumor eradication. Systematic evaluations in vitro and in vivo confirmed that nanomedicine enables highly effective MRI-guided synergistic chemo-photothermal and chemodynamic therapy. This work offers a promising therapeutic strategy for precise anti-tumor applications.

Bioresponsive Upconversion Nanostructure for Combinatorial Bioimaging and Chemo-Photothermal Synergistic Therapy

Bioresponsive and Near Infrared Photon Co-Enhanced Cancer Theranostic Based on Upconversion Nanocapsules

A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.

An Imaging-Guided Platform for Synergistic Photodynamic/photothermal/chemo-Therapy with Ph/temperature-Responsive Drug Release.

In situ crystal growth of gold nanocrystals on upconversion nanoparticles for synergistic chemo-photothermal therapy.

Multifunctional Core/satellite Polydopamine@nd 3+ -Sensitized Upconversion Nanocomposite: A Single 808 Nm Near-Infrared Light-Triggered Theranostic Platform for in Vivo Imaging-Guided Photothermal Therapy

Design, fabrication, luminescence and biomedical applications of UCNPs@mSiO2-ZnPc-CDs-P(NIPAm-MAA) nanocomposites.

An Intelligent Nanoplatform for Imaging-Guided Photodynamic/photothermal/chemo-Therapy Based on Upconversion Nanoparticles and CuS Integrated Black Phosphorus

Multifunctional core/satellite polydopamine@Nd3+-sensitized upconversion nanocomposite: A single 808 nm near-infrared light-triggered theranostic platform for in vivo imaging-guided photothermal therapy

808 nm photocontrolled UCL imaging guided chemo/photothermal synergistic therapy with single UCNPs-CuS@PAA nanocomposite.

A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging.

X-ray and NIR light dual-triggered mesoporous upconversion nanophosphor/Bi heterojunction radiosensitizer for highly efficient tumor ablation

An All-in-one Theranostic Nanoplatform Based on Upconversion Dendritic Mesoporous Silica Nanocomposites for Synergistic Chemodynamic/photodynamic/gas Therapy

Multifunctional UCNPs@PDA-ICG nanocomposites for upconversion imaging and combined photothermal/photodynamic therapy with enhanced antitumor efficacy

MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy

A Protein-Polymer Bioconjugate-Coated Upconversion Nanosystem for Simultaneous Tumor Cell Imaging, Photodynamic Therapy, and Chemotherapy

Upconversion Nanoparticle-Based Organosilica-Micellar Hybrid Nanoplatforms for Redox-Responsive Chemotherapy and NIR-Mediated Photodynamic Therapy

Upconversion Nanoparticle@Au Core-Satellite Assemblies for in Situ Amplified Imaging of MicroRNA in Living Cells and Combined Cancer Phototherapy

Biodegradable Theranostic Nanoplatforms of Albumin-Biomineralized Nanocomposites Modified Hollow Mesoporous Organosilica for Photoacoustic Imaging Guided Tumor Synergistic Therapy

Multifunctional Upconversion Mesoporous Silica Nanostructures for Dual Modal Imaging and in Vivo Drug Delivery

Ph/thermal Dual-Responsive Multifunctional Drug Delivery System for Effective Photoacoustic Imaging-Guided Tumor Chemo/photothermal Therapy.